CAMH News & Stories
In the headlines or behind the scenes, CAMH stories always aim to inform, engage, and enlighten.
SUMMIT Trial News Release
New study reveals promising strategies to provide the necessary support and treatment more effectively and inclusively for pregnant and postpartum populations.
Read More
CAMH is Canada’s Top Mental Health Research Hospital
Research spending surpasses $100 million, signaling unprecedented investment in mental health science and care.
Read More
Extended-Release Buprenorphine for Opioid Use Disorder Treatment in Correctional Settings
To understand treatment best practices, researchers at CAMH conducted the first comprehensive review of available studies that evaluate the use of extended-release buprenorphine as a treatment for OUD within correctional facilities.
Read More
CAMH and YouTube Health Partner to Promote Mental Health Literacy in Canada
In an effort to provide accessible, accurate, and high-quality health information to Canadians, YouTube and the Centre for Addiction and Mental Health (CAMH) are partnering as part of the global YouTube Health initiative.
About CAMH and YouTube Health Partner to Promote Mental Health Literacy in Canada
Our final phase of redevelopment: Discovery and Recovery
2024 kicks off the fourth and final stage of our historic redevelopment.
About Our final phase of redevelopment: Discovery and Recovery
CAMH Tops list of Mental Health Research Hospital Rankings
During the 2021-22 fiscal year, CAMH reached $86.6 million in research spending, a new record high and an 8.7 per cent increase over the prior year
About CAMH Tops list of Mental Health Research Hospital Rankings
Open Science momentum grows stronger in Canada with a new commitment by its largest mental health teaching hospital
CAMH joins the Tanenbaum Open Science Institute alliance in a partnership to open research practices.
About Open Science momentum grows stronger in Canada with a new commitment by its largest mental health teaching hospital
CAMH develops potential new drug treatment for multiple sclerosis
A small molecule drug that aids in the neuroprotection of cells found to be effective in treating nerve damage and symptoms in models of MS
About CAMH develops potential new drug treatment for multiple sclerosis
Canada’s 9-8-8: Suicide Crisis Helpline launches today
New three-digit suicide prevention helpline will take calls and texts, 24/7 anywhere in Canada
About Canada’s 9-8-8: Suicide Crisis Helpline launches today
Minor Variance for Phase 1D Redevelopment
The future Secure Care and Recovery Building is a Ministry of Health-funded project to build a new facility to better serve and care for patients with mental illness who have encountered the law.
About Minor Variance for Phase 1D Redevelopment
CAMH and LOFT partnership on youth housing
Transitional housing program will provide specialty care for youth with psychosis
About CAMH and LOFT partnership on youth housing
CAMH welcomes the release of Our Health Our City: A Mental Health, Substance Use, Harm Reduction and Treatment Strategy for Toronto
Integrating mental health, addictions, substance use and the social determinants of health is critical for addressing the complex challenges facing our city
About CAMH welcomes the release of Our Health Our City: A Mental Health, Substance Use, Harm Reduction and Treatment Strategy for Toronto
CAMH study finds that youth sports participation may mitigate genetic risk for mental illness
Study of nearly 5,000 nine- and 10-year-olds suggests playing non-contact or team sports may reduce problematic behaviours and symptoms in youth at risk for OCD
About CAMH study finds that youth sports participation may mitigate genetic risk for mental illness